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Abstract 
 The study was conducted to determine the effect of in vivo anti-plasmodial and in 
vitro antioxidant properties of methanolic leaf extract of Azadirachta indica and its positive 
effect on hematological and lipid parameters in Swiss albino mice infected with Plasmodium 
berghei NK65. Swiss albino mice were inoculated intraperitoneally with Plasmodium berghei 
NK65. The mice were grouped into six groups, five per group. Group I were not infected with 
P.berghei, Group II and III served as both the negative and positive  control while Group IV, 
V, and VI were treated with 200, 400, and 800 mg/kg body weight of methanolic leaf extract 
of  A. indica.  The secondary metabolites in the extract include tannin, flavonoids, glycosides 
and saponin etc. The extract does not have any toxic effect that can lead to the death of the 
animals. The median lethal dose LD50 was estimated to be >5000mg/Kg body weight. The 
extract caused 47.80%, 50.96% and 52.30% suppression in parasitaemia at 200, 400 and 
800mg/kg body weight respectively while Chloroquine exerted 100% suppression at 5mg/kg 
body weight. The curative test shows that the different concentration of the extract exert a 
growth inhibition of 50.1%, 74.57% and 73.68% at 200, 400, 800mg/kg body weight 
respectively while Chloroquine cleared the parasites by 94.07% at 5mg/kg body weight. The 
Hematological parameters showed that the extract is not hematotoxic since it significantly 
increase (P<0.05) RBC, HGB, and HCT values while their WBC count reduced significantly 
when compared to the infected untreated mice. There is a significant decrease (P<0.05) in 
plasma TC, TG and LDL-C in the treated groups and their HDL-C significantly increase 
when compared to infected untreated group. This study shows that  A.indica extract has 
hypolipidemic effect.  In the in-vitro antioxidant assay, the extract significantly increase 
(P<0.05) the level of SOD, CAT and GSH in the liver homogenate induced with oxidative 
stress using H2O2 while the MDA values reduced significantly with the administration of the 
extract of A.indica. 
 
Keywords: Azadirachta indica, Anti-plasmodial activity, hematological and lipid parameters, 
in-vitro antioxidant properties and Plasmodium berghei NK 65 infected Swiss mice 
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Introduction 
 Malaria is a disease caused by Plasmodium species, is one of the oldest and greatest 
health challenges affecting 40% of the world's population (Greenwood, 2002). About 300-500 
million clinical cases is observed and 1.2–2.8 million deaths occur each year due to malaria. 
(Linares and Rodriguez , 2007 and Sahu et al 2008). Severe malaria is a complex multisystem 
disorder. Complications such as cerebral malaria, anemia, acidosis, jaundice, coagulation 
anomalies, respiratory distress, renal insufficiency, and hyperparasitemia can occur in severe 
malaria (Penet et al 2005).Some of the problems associated with malaria are the control of 
mosquitoes which transmits malaria which is made difficult by their resistance to a wide 
range of insecticides. Secondly, is the production of fake anti malarial drugs.  Thirdly, most 
of the Plasmodial parasites are resistant to most widely available and affordable drugs like 
Chloroquine and Fansidar (Kisame,2005). Lastly, most countries in Africa lack the necessary 
infrastructure and resources to manage and control malaria (WHO, 1994). 
  Plasmodium berghei have been used in studying the activity of potential anti-
malarials in mice (Pedronic,et al.2006 ) and in rats (English, et al 1996 ). It produces diseases 
similar to those of human plasmodium infection (Kumar at al, 2006, Peter and Anatoli 1998 ) 
 Azadirachta indica, commonly known as Neem, is found in Nigeria and in most of the 
tropical and subtropical countries and is widely distributed in the world. The taxonomic 
classification of  Azadirachta indica is as follows: Kingdom Plantae, Order: Rutales, 
Suborder: Rutinae, Family: Meliaceae, Subfamily : Melioideae, Genus : Azadirachta, 
Species: indica (Girish et al, 2008). All parts of the plant are useful and have been used in 
treatment of diseases ranging from teeth decay, swollen liver, ulcers, dysentery, diarrhea, 
malaria and other bacterial infections. (Allameh et al., 2002 and Mossini et al., 2004). Studies 
have shown that the generation of reactive oxygen and nitrogen species (ROS and RNS) 
associated with oxidative stress, plays a crucial role in the development of systemic 
complication caused by malaria. Atamma et al 1993 observed that erythrocytes infected with 
Plasmodium falciparum produced OH- radical and H2O2 about twice as much compared to 
normal erythrocytes. Malaria infection induces the production of hydroxyl radicals (HO-) in 
the liver, which may be the reason for the induction of oxidative stress and apoptosis (Guha, 
2006).  
 
Materials and methods    
Collection and identification of Plant extract 
 The leaves of Azadirachta indica  were obtained from Ikorodu in Lagos State, 
Nigeria. The plant was authenticated by Miss Shokefun a botanist from Science Laboratory 
Technology Department, Environmental biology Unit, Lagos State Polytechnic, Ikorodu.  
 
Preparation of methanolic leaf extract of  Azadirachta indica   
 The leaves of  Azadirachta indica  were washed, air dried under shade in the 
Biochemistry Laboratory, pulverised to coarse power using blender. Extraction was carried 
out by dispersing 200g of the grounded A. indica plant material in 1L of 80% ethanol and 
shaking was done with GFL shaker for 72 hours. This was followed by vacuum filtration and 
concentrated by rotary evaporator at a temperature not exceeding 40oC. The concentrated 
extract was dried to complete dryness in an aerated oven at 40oC for 48 hours. The extract 
was latter stored in a refrigerator at 4oC. 
 
Phytochemical analysis 
 Phytochemical analysis for  phytochemical constituents were carried out on the 
methanolic extract of Azadirachta indica using standard phytochemical procedures (Sofowora 
(1993), Harborne (1973), Trease and Evans (1985).  
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Sources of Swiss albino mice 
 Eight (8) weeks old Swiss albino mice weighing 24- 35g were obtained from 
Nigeria Institute of Medical Research (NIMR), Lagos, Nigeria. These animals were 
maintained under laboratory conditions of temperature (22 to 24°C), humidity (40 to 
60%) and 12 h light/12 h dark regime at NIMR animal house.  They were acclimatized 
for three days, housed in plastic cages with saw dust as beddings; they were exposed to 
both food and water ad libitum for the entire duration of the study. The mice were used 
in accordance with NIH Guide for the care and use of laboratory animals; NIH 
Publication revised (1985) NIPRD Standard Operation Procedures (SOPs). 
 
Acute toxicity test 
 The acute toxicity test of nethanolic leaf extract of Azadirachta indica was 
carried out using modified Lorkes method (1993). Eighteen Swiss albino mice 
weighing 24 to 35 grams were randomized into three groups of six mice each and were 
given 1600, 2900 and 5000mg/Kg body weight of the extract orally. They were 
observed for signs of toxicity and mortality for the first critical four hours and 
thereafter daily for 7 days. The oral median dose LD50 was calculated 
 
Grouping of animals for infection and treatment 
 The parasite Plasmodium berghei NK 65 was obtained from Nigeria Institute of 
Medical Research (NIMR), Lagos, Nigeria from Dr Aina, O.O. The parasites were kept 
alive by continuous intraperitoneal inoculation of known amount of the parasite into 
Swiss mice. Iml of blood was taken from donor mice and diluted with 5ml phosphate 
buffer; such that 0.1ml contained standard inoculum of 1 7 infected red blood cells 
(Maegraith et al, 1952). Thirty acclimatized Swiss albino mice were randomly selected 
and twenty five Swiss mice were inoculated intraperitoneally from the same source to 
avoid variability in parasitemia. The mice were randomly distributed into six groups of 
five per group as shown below: 
 GROUP I (Normal control) Healthy uninfected Swiss mice 
 GROUP II (Negative control) mice infected with P.berghei NK65 without 
treatment 
 GROUP  III. (Positive control) = P.berghei +5mg/kg b,wt of Chloroquine 
(Standard drug) 
 GROUP IV= P. berghei +  200mg/kg b.wt of Azadirachta indica extract. 
 GROUP V=  P. berghei + 400mg/kg b.wt of Azadirachta indica  extract. 
 GROUP VI=P. berghei  + 800mg/kg b.wt  of Azadirachta indica  extract. 
 
Anti-plasmodium studies 
Suppressive test 
 The Peter’s 4-day suppressive test against P. berghei NK65 infection in Swiss mice 
was used (Peters, 1965). Adult Swiss mice weighing between 24 to 35gram were inoculated 
by intraperitonial injection with standard inoculum of Plasmodium berghei NK65 with 1 7  
infected red blood cells. The mice were divided into six groups as shown above and treated 
for 4 consecutive days with 5mg/kg.b.wt of Chloroquine, 200, 400, and 800mg/kg body 
weight of  Azadirachta indica  extract orally daily. On day 5 of the experiment, blood was 
collected from the tail of each mouse and smeared onto microscope slide to make a film.  
The blood films were fixed with methanol, stained with Geimsa at pH 7.2 for 10 minutes and 
examined under the microscope for the presence of parasites. The parasite density was 
calculated for each group by comparing the parasitaemia in infected group (Group II) with 
those of control and treated groups..  
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Curative test 
 The Curative test of methanolic leaf extract of  Azadirachta indica on another 
fresh infected Swiss albino mice were carried out according to the method described 
by Ryley and Peters, 1970.  The Swiss mice were injected intraperitoneally with 
standard inoculums of 1×107 Plasmodium berghei NK 65 infected erythrocytes on the 
first day (day 0). Seventy two hours later, thirty mice were divided into six groups of 
five mice per group as shown above. The treated groups were orally treated with 
5mg/kg b.wt of chloroquine, 200,400 and 800mg/kg b.wt of  Azadirachta indica 
respectively. The treatment was carried out once daily for 5 days, on each day of the 
treatment, blood was collected from the mice tail and smeared onto microscope slide 
to make thin and thick films. The blood films were fixed with methanol, stained with 
10% Giemsa at pH 7.2 for 10 minutes and examined microscopically to monitor the 
parasitaemia level. The parasite density was calculated for each group over a period of 
six days. 
 
Hematological analysis 
 The Swiss albino mice in the curative assay groups were sacrificed and their bloods 
were collected in EDTA bottles by ocular puncturing. The bloods in the EDTA bottles were 
assayed for hematological parameters using BC -3200 Auto Hematology Analyzer in Lagos 
University Teaching Hospital in Lagos- Nigeria. 
 
Lipid analysis 
 The Swiss mice used for Curative test were sacrificed and their blood were collected 
by ocular puncturing in an heparinized bottles, the blood were centrifuged for 10 minutes 
and the plasma removed for lipid assay. Total cholesterol (TC), Triglyceride (TG) and High 
Density lipoprotein-Cholesterol (HDL-C) were assayed in the plasma using Randox Kits 
(Trinder,1969, Tietze, 1990 and NIHCDCS, 1992).  Low density Lipoprotein-Cholesterol 
(LDL-C) were all calculated using formulae (Friedewald et al, 1972). 
 
In-vitro antioxidant assay 
 Two new healthy albino rats wistar strain with average weighing of 220 gram were 
scarified and their liver were removed and used for the assay. One gram of albino rat liver 
slice was taken in 4ml sterile PBS in flat bottom flask. H2O2 at 0.5M concentration was used 
as an oxidant for the induction of oxidative stress in the liver slices. 100μl of the methanolic 
leaf extract of Azadirachta indica  were added and later incubated for 1 hour at 37oC 
 Group A: 1g of untreated liver slice (negative control) 
           B: 1g of liver slice + H2O2 (positive control) 
           C: 1g liver slice + 200mg of Azadirachta indica extract 
           D: 1g liver slice + H2O2 + 200mg of Azadirachta indica extract 
           E: 1g liver slice + H2O2 + 400mg of Azadirachta indica extract 
           F: 1g liver slice + H2O2 + 800mg of Azadirachta indica extract 
 After incubation for 1 hour, an homogenate was prepared from the slices using 10% 
(W/V) PBS buffer. The homogenate was centrifuged at 1500rpm for 20 minutes to clarify the 
debris and the supernatant was used for the in-vitro antioxidant assay. 
 
Estimation of Lipid peroxidative (LPO) indices 
 Lipid peroxidation as evidenced by the formation of thiobarbituric acid (TBARS) and 
malondialdehyde (MDA) . These parameters were measured in the liver homogenate by the 
method of Niechaus and Sameulsson 1968 and Jiang et al, 1992. 
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Estimation of superoxide dismutase (SOD) 
 The homogenate was assayed for the presence of SOD by utilizing the technique of 
Magwere et al 1997 with slight modification. 
 
Estimation of catalase (CAT) 
 The liver homogenate was assayed for catalase colorimetrically at 620mm and 
expressed as μmoles of H2O2 consumed/min/mg protein as described by sinha,1972. 
 
Estimation of Reduced glutathione (GSH) 
 Reduced glutathione (GSH) was determined in the liver homogenate using the method 
of Ellman, 1959. 
 
Data analysis  
 Data analysis was done using the Graph Pad prism computer software. Student’s’-test 
and one-way analysis of variance (ANOVA) were used for comparison. A P-value < 0.05 was 
considered significant. 
 
Results 
 The results obtained from the phytochemicals analysis of  Azadirachta indica  
extract showed the presence of some secondary metabolite like tannins, saponins, 
flavonoids, protein, glycoside,  reducing sugar and fats and oil. (Table I). The presence 
of these secondary metabolites in this extract may be responsible for the anti-
plasmodial activity of the extract. 
 Table 1: The phytochemical constituents of the methanolic leaf extract of  Azadirachta indica.  
Phytochemical components Qualitative abundance 
Tannins 
Ferric Chloride test ++ 
Saponins 
Frothing test ++ 
Alkaloids 
Wagners test +++ 
Steroids 
Salkowiski test - 
Terpenoids + 
Flavonoids 
Ammonium test + 
Test for protein 
Millions test 
Biuret test 
+ 
+ 
Test for fat and oil ++ 
Test for reducing sugar ++ 
Glycoside + 
+ (Present in low concentration), ++ (present in moderate concentration) and  -(absent) 
 
Azadirachta indica  toxicity test 
 The mice were monitored for four hours, but no signs of toxicity were observed. The 
behavioural and physical observations revealed no involuntary urination, muscle weakness, 
and convulsion. The animals were physically active for the first four hours.  
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Figure I.Suppresive test showing the effect of methanolic leaf extract of
A,indca on Swiss mice infected with Plasmodium berghei NK65.
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Figure 2.Curative test showing the effect of methanolic leaf extract of
A.indica on Swiss mice infected with Plasmodium berghei NK65.
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 The methanolic leaf extract of  A.indica caused 47.80%,  50.96% and 52.30% 
suppression in parasitaemia of P.berghei NK65 infected mice at 200, 400 and 
800mg/kg body weight respectively (Figure 1), while Chloroquine, a standard anti-
malarial drug used exerted 100% suppression at 5mg/kg body weight. The curative test 
shows that the different concentration of the extract of A. indica exert a growth 
inhibition of  50.1%, 74.57% and  73.68% at 200, 400, 800mg/kg body weight of the 
extract respectively while Chloroquine, the standard drug, cleared the parasites by 
94.07% at 5mg/kg body weight (Figure 2). 
Table 2: Curative test showing the effect of methanolic leaf extract of Azadirachta indica and chloroquine on 
hematological parameters of Swiss albino mice infected with P.berghei NK65.  
Hematological 
Parameters 
GROUP 
I 
GROUP 
II 
GROUP 
III 
GROUP 
IV 
GROUP 
V 
GROUP 
VI 
WBC (X 109/L) *15.9±4.50 69.7±10.40 *39.20±7.1 *49.6 ±6.20 *45.5±3.60 *36.50 ±5.2 
PCT 
(%) 
0.4640 
± 0.090 
0.345 
±0.058 
0.258 
±0.042 
0.312 
±0.062 
0.282 
±0.060 
0.305 
±0.072 
MPV (fL) 6.10 ± 0.50 8.1 ± 0.30 7.6 ± 0.30 7.7 ± 0.30 7.9 ± 0.40 7.1 ± 0.30 
PDW 14.10±0.20 15.80±0.70 15.10±0 .30 15.2±0.40 15.40±0.60 15.0±0.10 
HGB   (g/dl) *12.9±0.10 4.50 ±0.90 *9.30±0.30 *6.80±0.30 *7.70±0.50 *7.10±0.60 
RBC (X 1012/L) *8.20±0.03 *2.65 ± 0.30 5.40±0.30 *5.33±1.20 *5.00±1.42 *4.48±0.20 
HCT(%) *42.5±2.20 17.2±1.00 *32.50±1.2 *25.4±0.3 *26.1±0.7 *23.1±0.8 
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MCV (fL) 55.7±4.10 68.0±0.30 63.50±0.20 73.20 ± 0.20 75.20±0.20 70.3±3.60 
MCH (Pg) 15.5±0.40 18.4±0.40 16.8±0.10 18.50±0.40 20.30±1.10 18.10±0.10 
MCHC (g/dL) 31.9±0.80 25.2±0.23 25.4±0.21 25.3±0.30 28.2±0.50 26.9±0.30 
RDW-CV (%) 18.10±0.20 20.50±0.70 18.00±0.30 19.82±0.40 21.90±1.40 19.40±0.50 
RDW-SD (fL) 30.50±1.60 46.60±1.40 37.80±0.70 47.50±5.30 51.1±7.70 47.7±0.90 
 
 Values are expressed in mean ± SD of five mice in each group. * indicate Significant 
difference when compared to negative control (P <0.05). WBC: White blood cell; PCT: Mean 
platelet volume; MPV: Mean platelet volume; PDW: Platelet Distribution Width; HGB: 
Hemoglobin Concentration; RBC: Red Blood Cell; HCT: Hematocrit; MCV: Mean 
corpuscular volume; MCH: Mean Cell hemoglobin; MCHC: Mean Cell hemoglobin 
concentration; RDW–CV: RBC distribution width–coefficient of variation; RDW–SD: RBC 
distribution width–standard deviation. 
 The total WBC counts were significantly lowered ( P<0.05) by 28.12%, 33.72% and 
48.63% following A. indica extract administration at different dosage. The treated groups all 
showed elevated WBC counts when compared to Group I (healthy mice). This is caused by 
the Plasmodium berghei infection present in the treated group.  The mean HGB values are 
significantly increased by 34.12%, 41.68% and 36.16% on administration of the extract of A. 
indica at different dosage compared to the untreated infected mice. Treatment with 200, 400 
and 800mg/kg body weight of the extract significantly (P<0.05) increase the RBC values by 
50.80%, 48.10% and 41.12% respectively when compared to group II mice. The HCT values 
of the groups treated with A. indica were significantly increased by 33.03%, 34.94% and 
26.07% respectively when compared to infected untreated group. (Table 2). There are no 
significant differences in the other hematological parameters of the infected untreated group 
compared to other group.     
Table 3: The effect of Chloroquine and methanolic leaf extract of  Azadirachta indica treatment on plasma 
Lipid profile of healthy and infected Swiss mice.  
Lipid profile GROUP I 
GROUP 
II 
GROUP 
III 
GROUP 
IV 
GROUP 
V 
GROUP 
VI 
Total cholesterol 
(TC) mg/dl 
*70.80 ± 
4.40 87.33 ± 4.30 
*72.50 ± 
4.20 
*71.52  ± 
3.30 
*70. 20 ± 
3.20 
*66.40 ± 
2.80 
Triglyceride (TG) 
mg/dl 
*64.20 ± 
4.23 79.85 ± 3.23 
*66.30. ± 
3.40 *63.60 ± 2.40 
*61.30 ± 
4.70 
*60.50 ± 
3.60 
HDL –C mg/dl *39.90 ± 2.60 27.42 ± 4.10 
*32.40 ± 
2.15 *37.30 ± 3.40 
*33.10 ± 
3.40 
*39.40 ± 
2.40 
LDL-C  mg/dl *18.33 ± 0.31 40.21 ± 2.10 
*25.40 
±2.21 *22.25 ± 1.60 
*23.40 ± 
2.60 
*17.40 ± 
1.60 
Values are expressed in Mean  SD of five mice in each group. * indicate Significant difference when compared 
to negative control (P <0.05). 
 
 From Table 3, plasma TC is reduced by 18.93%, 19.83% and 24.03% respectively on 
administration of the different dosage of the extracts in the treated groups compared to the 
untreated infected group. The values of the plasma TG in group IV to VI were reduced by 
20.35%, 23.63% and 24.01% respectively on administration of the extract. The different 
dosage of the extract significantly reduce the low density lipoprotein-Cholesterol (LDL-C) by 
44.67%, 42.12% and 56.02%  respectively after treatment compared to the untreated infected 
group. However, significant decreases (P < 0.05) in plasma TC, TG and LDL-C levels in 
infected mice treated with chloroquine were also observed. The HDL-C values were 
increased by 25.82%, 17.09% and 31.02% respectively on treatment with the extract 
compared to untreated infected group. 
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 Table 4: In-vitro antioxidant activity of Azadirachta indica on H2O2 induced oxidative stress on liver tissue. 
Oxidative stress 
Parameters 
GROUP 
A 
GROUP 
B 
GROUP 
C GROUP D 
GROUP 
E 
GROUP 
F 
Lipid Peroxidation 
X 103 mm MDA/mg 
protein 
*4.70±1.20 9.20±3.40 *3.11±1.20 *5.20±1.30 *4.90±1.60 *3.90±1.50 
Catalase (CAT) 
unit*/ mg protein *41.20±4.10 22.20±4.20 *47.10±3.40 *30.20±4.2 *31.50±3.5 *38.20±3.1 
Superoxide 
dismutase (SOD) 
unit*/ mg protein 
*11.30±0.80 4.60±0.50 *11.80±1.20 *8.60±0.70 *7.40±1.60 *8.50±1.30 
Reduced 
glutathione (GSH) 
mg/mg protein 
*0.41±0.09 0.13±0.02 *0.32±0.08 *0.26±0.07 *0.24±0.03 *0.22±0.06 
Values are expressed in Mean  SD of five mice in each group. * indicate Significant difference when compared 
to negative control (P <0.05). 
 
 MDA is the major oxidation product of peroxidized poly-unsaturated fatty acids and 
the increased MDA content is an important indicator of lipid peroxidation. Table 4 shows that 
the group treated with A.indica extract dosage of 200, 400 and 800mg/kg body weight 
significantly reduce the MDA liver homogenate level by 43.82%, 45.98% and 57.28%,  
respectively compared to the untreated group B. Group C reduces the MDA level by 66.81% 
when compared to group B. Catalase is an enzymatic antioxidant widely distributed in all 
animal tissues. Catalase decomposes hydrogen peroxide and helps protect the tissues from 
highly reactive hydroxyl Radicals. The CAT liver homogenate was also increased by the 
administration of A.indca  extract by 53.80%, 26.88%, 28.45% and  43.26% respectively 
(group C to F). SOD has been touted as one of the most important enzymes in the enzymatic 
anti-oxidant defense system. SOD level is increased by the administration of the different 
extract of A.indica  by 61.82%, 47.062%, 38.54% and 46.63% respectively (group C to F). 
The GSH liver homogenate values increased by 59.38%, 50.20%, 45.58% and 40.64% 
respectively on the administration of different extract of A.indica.    
  
Discussion 
 The result of this study shows that methanolic leaf extract of A. indica contain some  
secondary metabolites like tannin, saponin, glycoside, reducing sugar  and flavonoids (Table 
1). The presence of these secondary metabolites in A. indica may be responsible for the plant 
anti-plasmodium activity. It is evident by these findings that A. indica possessed anti-
plasmodium activity justifying its usage in the management of malaria. Milliken, 1997, 
Christensen and Kharazmi, 2001 showed clearly that  anti-plasmodial screening of plant 
substances may be caused by terpenes, flavonoids and alkaloids. These compounds could be 
acting singly or in synergy with one another to exert the anti-plasmodial activity observed in 
this study.  
 No death occurred during toxicity test at all the dose level used which shows that the 
extract does not have any toxic effect that can lead to the death of the animals. The median 
lethal dose LD50 was estimated to be >5000mg/Kg body weight. Behavioral signs of toxicity 
like salivation, paw licking, restlessness, reduced activities and stretching were observed. 
 The four day suppressive test is a standard test commonly used for anti-malarial 
screening, and the determination of percentage inhibition of parasitaemia is the most reliable 
parameter.  The results obtained from this study showed significant decrease in parasitaemia 
of P. berghei  after  treatment with the extract of  A. indica. The significant decrease in 
parasitaemia observed in this study was dose dependent.  The methanolic leaf extract of A. 
indica caused 47.80%, 50.96% and 52.30% suppression in parasitaemia of P.berghei  at 200, 
400 and 800mg/kg body weight respectively while chloroquine, a standard anti-malarial drug 
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used exerted 100% suppression at 5mg/kg (Figure 1). When a standard anti-malarial drug is 
used in mice infected with  P. berghei, it suppresses the parasiteamia to a non-dectable level 
(Kiseko,et al 2000). The curative test shows that only chloroquine cures the parasites from 
day 3 of treatment while the different concentration of the extract of A. indica exert a growth 
inhibition of  50.10%, 74.57% and 73.68% respectively. Studies showed  that the in vitro 
anti-malarial activity of A. indica, previously reported by El-Tahir et al in 1999, indicate that 
an aqueous extract of Neem leaves showed an IC50 value <5 μg/ml against P. falciparum. 
Similar results were obtained by Alshawsh and colleagues in 2007, where they reported that 
aqueous A. indica extracts inhibited the development of the ring stage of P. falciparum. 
 Hematological and biochemical indices have been reported to be a reliable parameter 
for assessment of the health status of animals (Sexena ,et al 2011 and Ohaeri, 2011). WBC 
count functions primarily in body defence against foreign bodies and this is often achieved 
through leucocytosis and antibody production (Marieb, 1995).There was a significant 
increase (P < 0.05) in the WBC count in group II mice compared to all other groups treated 
with A.indica extract (Table 2). Leukocytosis observed in group II may be due to luekemia, 
bone marrow tumors, tissue damage and inflammatory disease of the mice infected with 
P.berghei NK65. There were significant reduction (P<0.05) in HGB, RBC and HCT of the 
untreated infected mice compared to the group treated with chloroquine and A.indica  extract . 
This is an indication of severe anemia in group II animals. The extract prevented a drastic 
reduction in HGB, RBC and HCT values, features signifying severe anemic conditions. This 
observation is supported by a report stating that anemia is characterized by decreased values 
of HGB, RBC and HCT (Aleksandro,2009). There were no significant change (P<0.05) in the 
MCV, MCH, MCHC, PCT, PDW, RDW-CV and RDW-SD values in the entire experimental 
groups. This study shows that  the methanolic leaf of A.indica extract does possess 
hematopoietic activity and is not hematotoxic. 
 Several studies have shown that high plasma total cholesterol, triglyceride and LDL- 
cholesterol are the major cause of cardiovascular disease. There were significant increase 
(P<0.05) in plasma TC, TG and LDL-C in the untreated infected group compared to other 
groups. The extract significantly reduces (P<0.05) these lipid parameters (TC, TG and LDL-
C) by an average of 20.93%, 22.66% and 47.60% respectively for the entire treated group 
(Table 3). This is an indication that A. indica may be used to prevent cardiovascular 
infections.  This observation is consistent with report from earlier study by Onyeneke et al. 
1997.They showed that there were increased in serum lipoprotein fractions in malarial 
patients compared with apparently healthy control subjects. The extract significantly increase 
(P<0.05) HDL-C in the treated groups by 25.82%, 17.09% and 31.02% respectively 
compared to the infected untreated animals. Njoku and colleque (2001) also reported 
significant increase in HDL- cholesterol levels of malaria patients treated with crude neem 
extracts relative to both malaria controls and chloroquine treated patients. 
 Liver is the major organ used for removing Xenobiotic substances from the body and 
as such it possesses a high metabolic rate and is subjected to many substances causing 
oxidative stress. The host system produces reactive oxygen and nitrogen species (ROS and 
RNS) in response to infection. The parasite is capable of producing free radicals, which 
interfere with the biochemistry of red blood cells and may facilitate the internalization of the 
parasite into hepatocytes and RBC. Malondialdehyde (MDA) concentration was used as an 
index for lipid peroxidation. The liver homogenate MDA value was significantly higher 
(P<0.05) in group B compared to other groups (Table 4). The result of lipid peroxidation in 
the liver homogenate of the group treated with the different doses of  A. indica showed the 
least value. This is an indication that the extract reduces oxidative stress since increased in 
lipid peroxidation has been linked to cause oxidative stress. Evidence has shown that ROS 
like H2O2 are implicated in ethanol induced lipid paroxidation (Schlorff et al 1999). SOD is 
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one of the most important enzyme in the enzymatic anti-oxidant defense system. SOD 
catalyses the dismutation of superoxide anion (02-) to form H2O2. CAT decomposes the H2O2 
to form water and oxygen. SOD and CAT values in the liver homogenate were significantly 
lowered ( P<0.05) in group B compared to other group (group A, C, D, E and F). Group C has 
the highest values for SOD and CAT respectively. The reduced levels of SOD and CAT in 
group B liver homogenate clearly indicate hepatocytes necrosis due to production of reactive 
metabolities induced ROS production. Pegeolot et al 1990 observed that decreased in SOD 
and CAT could be due to feed back inhibition or oxidative inactivation of enzyme protein due 
to excess ROS generation. GSH acts as a free radical scavenger, a generator of α-tocopherol 
and plays an important role in the maintenance of protein sulfhydryl groups (Farnandez, and 
Videla, 1981). Group A, C, D, E and F showed significant  higher GSH values (P<0.05) 
compared to group B. Low GSH value has been implicated with oxidative stress. Farnandez, 
and Videla, 1981 showed that acute ethanolic ingestion, depletes GSH levels which lead to 
oxidative stress. The above result showed clearly that A.indica  possess antioxidant potentials. 
 
Conclusion 
 The result obtained from this study reveals that 200, 400 and 800mg/kg body weight 
of methanolic  leaf extract of Azadirachta indica. suppresses Plasmodium berghei NK 65 and 
could be used in the management of malaria. The extract is not hematotoxic, it has 
hypolipidemic effect and possess antioxidant properties.  
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